Fortress Biotech, Inc. Financial Ratios — FBIOP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-441.37	-134.14	-71.93	-26.86	-76.04	-115.57	-146.87	-309.23	-284.77	-73.53	-61.91	-125.82	-213.73	-246.89	-5.18
Return on Assets (%)	-311.1	-85.79	-52.49	-21.47	-46.58	-38.08	-32.1	-43.49	-21.75	-16.62	-17.73	-25.06	-26.26	-29.51	4.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	31.13	78.79	77.22	71.25	67.99	53.36	59.37	72.91	63.8	66.92
EBITDA Margin (%)	- -	- -	- -	- -	-5,852.26	-391.89	-513.4	-438.72	-289.84	-195.06	-250.34	-256.41	-157.61	-185.13	-103.63
Operating Margin (%)	- -	- -	- -	- -	-5,855.27	-398.73	-520.71	-446.38	-302.54	-206.74	-260.21	-268.76	-164.71	-192.87	-111
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-6,243.68	-432.58	-565.46	-486.57	-277.54	-225.55	-238.92	-281.83	-181.79	-209	-53.01
Profit Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-114.3	-71.75	-79.75	10.77
Net Income to Common Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-124.91	-81.25	-96.91	-2.97
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	13.88	- -	- -	- -	- -	- -	-0.23	-1.24	-1.57	-4.23	-3.31	-0.21	-0.29	2.52	9.88
Sustainable Growth Rate (%)	-380.1	-134.14	-71.93	-26.86	-76.04	-115.57	-147.21	-313.08	-289.23	-76.64	-63.97	-126.09	-214.34	-240.67	-4.67

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
ST Debt	- -	2	6	- -	- -	2	13	19	9	6	7	13	6	3	2
LT Debt	1	13	7	14	23	26	49	60	106	83	68	115	79	73	72
Total Debt/EBITDA	-0.02	-0.54	-0.38	-0.7	-0.46	-0.44	-0.71	-0.67	-1.08	-1	-0.44	-0.66	-0.64	-0.71	-1.13
Net Debt/EBITDA	0.64	0.94	2.4	1.73	1.49	0.93	0.37	-0.12	0.44	1.9	1.47	0.39	0.13	-0.01	0.3
Total Debt/EBIT	-0.02	-0.54	-0.38	-0.7	-0.46	-0.43	-0.7	-0.66	-1.04	-0.94	-0.42	-0.63	-0.61	-0.68	-1.06
Net Debt/EBIT	0.64	0.94	2.4	1.73	1.48	0.91	0.36	-0.12	0.43	1.79	1.42	0.37	0.12	-0.01	0.28
EBITDA to Interest Expense	-473.27	-40.56	-18.6	-15.42	-34.03	-17.5	-11.52	-11.41	-12.45	-9.17	-15.11	-18.64	-11.18	-9.21	-7.53
EBITDA-CapEx/Interest Expense	-525.2	-40.97	-18.7	-15.42	-42.11	-20.35	-12.04	-12.31	-13.55	-9.9	-16.55	-18.94	-11.86	-10.51	-7.53
EBIT to Interest Expense	-473.57	-40.56	-18.61	-15.43	-34.05	-17.81	-11.68	-11.61	-12.99	-9.71	-15.71	-19.54	-11.68	-9.6	-8.06
Interest Expense	- -	1	2	1	1	4	8	10	9	10	11	10	12	12	9
Common Equity/Total Assets	81.85	53.75	80.81	78.95	47.93	22.55	21.38	1.31	11.58	30.09	27.41	14.18	13.46	15.76	26.88
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	3.77	34.91	7.81	16.8	21.54	23.55	26.92	60.88	56.55	28.91	22.45	64.68	91.76	97.84	52.88
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
Net Debt to Equity	-117.13	-116.26	-105.69	-50.7	-89.01	-72.41	-26.93	70.89	-65.09	-85.79	-112.39	-149.81	-1,075.68	-80.54	-31.97
Net Debt/Capital (%)	683.65	714.93	1,857.36	-101.58	-797.02	-262.48	-36.86	41.48	-92.91	-320.57	5,191.37	8,354.63	-320.82	7.76	-34.81
EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
EBITDA-CapEx	-39	-27	-36	-21	-62	-75	-93	-127	-116	-96	-189	-197	-141	-122	-66
Operating Income (Loss)	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.63	7.83	8.88	17.11	9.28	1.62	1.83	1.49	3	4.51	3.03	1.4	0.95	0.8	1.6
Current Ratio	6.69	7.91	8.92	17.28	9.45	1.94	2.56	2	3.43	5.14	3.43	1.8	1.38	1.27	2.49
Quick Ratio	6.63	7.83	8.88	17.11	9.3	1.77	1.95	1.63	3.32	4.98	3.26	1.62	1.13	0.95	2.2
CFO/Avg Current Liab	-6.27	-5.38	-3.63	-2.14	-2.78	-1.36	-1.27	-1.56	-1.88	-1.72	-1.53	-1.57	-1.21	-1.03	-1.09
Common Equity/Total Assets	81.85	53.75	80.81	78.95	47.93	22.55	21.38	1.31	11.58	30.09	27.41	14.18	13.46	15.76	26.88
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	3.77	34.91	7.81	16.8	21.54	23.55	26.92	60.88	56.55	28.91	22.45	64.68	91.76	97.84	52.88
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
CFO/Total Liabilities	-258.12	-122.34	-153.57	-86.87	-59.35	-52.2	-64.81	-81.52	-61.71	-61.34	-68.3	-73.44	-77.27	-54.98	-53.32
CFO/CapEx	-2.85	-83.13	-157.69	- -	-1.7	-4.36	-20.26	-10.57	-10.11	-11.68	-7.13	-58.72	-15.83	-5.35	- -
Altman's Z-Score	-7.32	-4.02	-1.8	-2.09	-2.77	-3.56	-2	-5.87	-3.29	-1.61	-1.97	-4.77	-8.24	-11.02	-5.56

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	18.01	3.6	4.06	3.85	2.43	2.92	2.95	3.89	4.53	3.16
Days Sales Outstanding	- -	- -	- -	- -	- -	20.27	101.47	89.99	94.85	149.95	124.8	123.65	93.78	80.54	115.43
Inventory Turnover	- -	- -	- -	- -	- -	111.81	19.56	14.43	13.72	12.91	5.7	2.56	1.88	1.69	1.74
Days Inventory Outstanding	- -	- -	- -	- -	- -	3.26	18.66	25.3	26.6	28.27	64.08	142.45	194.23	215.35	209.81
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.67	0.14	0.21	0.31	0.65	1.38	0.67	0.41	0.76	0.7
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	548.72	2,613.64	1,701.99	1,187.03	564.86	264.87	544.67	887	483.05	519.45
Cash Conversion Cycle	- -	- -	- -	- -	- -	-525.19	-2,493.51	-1,586.7	-1,065.58	-386.63	-75.99	-278.57	-598.99	-187.16	-194.21
Inventory to Cash Days	- -	- -	- -	- -	- -	17	82.81	64.7	68.25	121.68	60.71	-18.79	-100.45	-134.81	-94.38
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	1	10	14	10	14	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	6	5	3	3
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	8	5	11	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	77	55	101	123	175	130	179	186	298
- Cash & Cash Equivalents	23	40	100	50	98	88	95	66	137	233	306	178	81	57	79
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	27	44	68	18	46	97	117	8	-21	-24	12
+ Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
Enterprise Value	-22	-26	-86	-55	-47	-19	77	70	126	75	61	87	162	180	305
Total Capital	20	37	95	85	108	111	183	99	188	286	301	177	86	74	136
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt / EV	-0.03	-0.57	-0.16	-0.26	-0.49	-1.49	0.81	1.14	0.92	1.19	1.22	1.46	0.52	0.42	0.24
EV/Sales	- -	- -	- -	- -	- -	- -	4.45	2.6	3.43	1.65	0.89	1.15	1.92	3.12	4.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-22	-26	-86	-35	-47	-16	35	32	25	-48	-114	-43	-17	-6	7
EV per Share	- -	- -	- -	- -	- -	- -	22.6	18.09	25.47	11.86	9.09	11.86	10.73	6.45	9.72
TTM Sales	- -	- -	- -	- -	1	16	17	27	37	46	69	76	85	58	63
TTM EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
TTM Operating Income	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70
TTM Cash Flow to Firm	-11	-23	-28	-15	-19	-42	-73	-89	-86	-74	-105	-169	-116	-69	-57
TTM Free Cash Flow to Firm	-7	-22	-28	-15	-7	-32	-69	-79	-77	-67	-89	-166	-108	-54	-57

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-22	-26	-86	-55	-47	-19	77	70	126	75	61	87	162	180	305
Low Price	- -	- -	- -	- -	- -	- -	20.01	11.9	14.13	12	19.31	16.86	6.4	4.86	4.72
EV/Sales	- -	- -	- -	- -	- -	- -	4.45	2.6	3.43	1.65	0.89	1.15	1.92	3.12	4.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	1.47	29.98	3.86	1.22	1.61	3.12	7.95	8.16	5.97
Price/Book Value Average	- -	- -	- -	- -	- -	- -	1.5	41.8	3.79	1.18	1.55	3.71	10.56	13.39	4.55
Price/Book Value High	- -	- -	- -	- -	- -	- -	1.6	49.92	4.13	1.36	1.66	4.66	13.63	22.1	6.19
Price/Book Value Low	- -	- -	- -	- -	- -	- -	1.29	24.79	2.66	0.76	1.2	2.98	4.29	5.97	2.97
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	1.5	127.86	5.37	1.43	1.82	8.95	79.48	-20.33	13.37
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	1.52	178.29	5.27	1.38	1.75	10.65	105.56	-33.34	10.2
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	1.63	212.9	5.75	1.59	1.88	13.4	136.27	-55.03	13.88
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	1.32	105.74	3.7	0.89	1.36	8.55	42.86	-14.86	6.65
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	6.62	4.06	3.38	1.54	0.79	1.48	2.61	5.18	3.7
EV/Sales High	- -	- -	- -	- -	- -	- -	6.95	4.62	3.63	1.94	0.97	2.01	3.43	8.61	5
EV/Sales Low	- -	- -	- -	- -	- -	- -	6	2.89	2.58	0.62	0.25	1.08	0.94	2.25	2.45
EV/EBITDA Average	0.64	0.94	2.4	1.71	0.94	0.24	-1.29	-0.93	-1.17	-0.79	-0.32	-0.58	-1.66	-2.8	-3.57
EV/EBITDA High	0.64	0.94	2.4	1.71	0.94	0.24	-1.35	-1.05	-1.25	-1	-0.39	-0.78	-2.18	-4.65	-4.82
EV/EBITDA Low	0.64	0.94	2.4	1.71	0.94	0.24	-1.17	-0.66	-0.89	-0.32	-0.1	-0.42	-0.6	-1.22	-2.37
EV/EBIT Average	0.64	0.94	2.4	1.71	0.94	0.24	-1.27	-0.91	-1.12	-0.75	-0.3	-0.55	-1.59	-2.68	-3.34
EV/EBIT High	0.64	0.94	2.4	1.71	0.94	0.24	-1.33	-1.04	-1.2	-0.94	-0.37	-0.75	-2.08	-4.46	-4.5
EV/EBIT Low	0.64	0.94	2.4	1.71	0.94	0.24	-1.15	-0.65	-0.85	-0.3	-0.1	-0.4	-0.57	-1.17	-2.21
Last Price	- -	- -	- -	- -	- -	- -	22.75	14.39	20.48	19.39	25.88	17.65	11.87	6.65	9.49
High Price	- -	- -	- -	- -	- -	- -	24.8	23.96	21.95	21.54	26.69	26.41	20.35	18	9.85
Enterprise Value Average	-22	-26	-86	-35	-47	-16	114	109	124	70	54	112	221	299	234
Enterprise Value High	-22	-26	-86	-35	-47	-16	120	124	133	89	67	152	290	497	316
Enterprise Value Low	-22	-26	-86	-35	-47	-16	103	78	94	28	17	82	79	130	155

Shares Outstanding	1	2	3	3	3	3	3	4	5	6	7	7	15	28	31
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	18.67	24.71	37.65	22.51	31.24	28.1	38.52	21.55	27.73	36.89	45.21	24.2	5.36	2.05	2.53
Book Value per Share	15.43	13.54	30.75	22.75	18.09	11.8	15.46	0.48	5.31	15.86	16.07	5.66	1.49	0.81	1.59
Tangible Book Value per Share	15.43	13.54	30.75	22.75	17.69	0.75	15.21	0.11	3.82	13.55	14.21	1.97	0.15	-0.33	0.71

Fortress Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)